Misguided Alzheimer's Research

The discussion highlights the misguided focus on amyloid plaques in Alzheimer's research, with the belief that a single drug can reverse decades of brain damage being viewed as unrealistic. Both Sal and Max emphasize the financial motivations behind pharmaceutical investments, noting that lifestyle changes like diet and exercise are often overlooked due to their lack of profitability. This conversation challenges the prevailing narratives in Alzheimer's treatment and underscores the need for a broader approach to brain health.